MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufactu... ( VALENCIA Calif. March 9 /- MannKind C...)

MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufacturing Plant

Date:3/9/2009

VALENCIA, Calif., March 9 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD) today announced that it has entered into agreements with Pfizer Inc. (NYSE: PFE) to purchase Pfizer's insulin facility at Industriepark Hoechst, Frankfurt am Main, Germany and assets related to the production of bulk insulin, including the relevant real property rights, the production equipment, a quantity of bulk insulin and a license to manufacture bulk insulin for use in pulmonary delivery. The aggregate purchase price is $33 million, subject to certain adjustments. At MannKind's option, up to $30 million worth of the company's common stock may be issued to Pfizer at closing and applied toward the full purchase price. The transfer of certain real property rights pursuant to this transaction will require the consent of third parties.

Upon the closing of this transaction, MannKind intends to retain more than half of the current workforce, subject to consultation with the works council and employee co-determination rights, and plans to operate the facility at a production level commensurate with the company's present needs for recombinant human insulin.

In the event some or all of the third-party consents are not obtained, only the bulk insulin, the license to manufacture bulk insulin for use in pulmonary delivery and, potentially, certain removable equipment will be transferred to MannKind at closing.

"The insulin plant in Frankfurt is a state-of-the-art insulin production facility that would make an excellent counterpart to our formulation, fill and finish facility for AFRESA in Danbury, Connecticut," said Alfred Mann, Chairman and Chief Executive Officer of MannKind Corporation. "Upon the closing of this transaction, we will
'/>"/>

SOURCE MannKind Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on February 17, 2009
2. MannKind to Present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference
3. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
4. MannKind to Present at the Piper Jaffray 20th Annual Health Care Conference
5. MannKind to Present at the Rodman & Renshaw Annual Global Investment Conference
6. MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008
7. MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility
8. MannKind to Present at the UBS Global Life Sciences Conference
9. MannKind Corporation Reports Second Quarter Financial Results
10. MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
11. MannKind to Present at Upcoming Conferences

Post Your Comments:

(Date:6/18/2013)... KONG, June 18, 2013 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2013 ended March 31, 2013. Fourth ... the fourth quarter of fiscal 2013 increased by 33.3% ...

(Date:6/18/2013)... PA (PRWEB) June 18, 2013 Demanding ... Ball Lenses engineered of synthetic Sapphire and Glass Ball ... sizes from Swiss Jewel Company , of Philadelphia ... by expanding and collimating the light beams without the ... optical clarity and natural durability (9 mohs) make it ...

(Date:6/18/2013)... JERUSALEM , June 18, 2013 ... study using the company,s proprietary AMCA Guided Bone Regeneration (GBR) ... dental implants. A common problem encountered when patients ... lack of sufficient bone volume to house the implant. Consequently ... a bone substitute until the natural bone regenerates. The bone ...

(Date:6/18/2013)... 2013 AMRI (NASDAQ: AMRI ) ... , site has received approval to expand ... to handle Schedule 2 and 2N controlled substances. ... Burlington,s physical security and quality ... (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) With ...

[0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors [0] RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants [0] AMRI Burlington Receives DEA Approval to Handle Controlled Substances

... /PRNewswire-Asia/ -- Moleac has been named the,Singapore Entrepreneurial ... This award,recognizes companies that have pushed the boundaries ... outstanding performance in 2008.,Mr David Picard, CEO of ... Excellence in Healthcare Award for Singapore Entrepreneurial Company,of ...

... Data Show AEZS-126 as Promising Oral Compound for , ... - AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: ... therapy and oncology, today presented two posters on AEZS-126, ... Akt pathway in human tumors. The posters were presented ...

... HUBBARD, Ohio, April 21 NanoLogix, Inc. (OTC: NNLX) ... square foot manufacturing facility at its headquarters in Hubbard, ... vault, and shipping and receiving area to be used ... revolutionary new BNP(TM) kits provide accelerated detection of bacteria ...

Cached Biology Technology:Moleac Named Singapore Entrepreneurial Company of the Year at the Frost & Sullivan Excellence in Healthcare Awards 2 Moleac Named Singapore Entrepreneurial Company of the Year at the Frost & Sullivan Excellence in Healthcare Awards 3 AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting 2 AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting 3 NanoLogix Begins Construction of Production Facility for Medical Test Kits 2 NanoLogix Begins Construction of Production Facility for Medical Test Kits 3

Moleac Named Singapore Entrepreneurial Company of the Year at the Frost & Sullivan Excellence in Healthcare Awards AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting NanoLogix Begins Construction of Production Facility for Medical Test Kits

(Date:6/18/2013)... The Association for Molecular Pathology is proud to announce ... Experimental Biology (FASEB) on July 1, 2013. The FASEB ... 2013. , The 26 constituent societies of FASEB ... vision for the advancement of research and education in ... is more important now than ever," said Jennifer L. ...

(Date:6/18/2013)... chemical modification of DNA and this modification can ... sequence. Until now, scientists believed that this epigenetic ... Today, a team of researchers from the University ... Louis-Jeantet Professor at the Faculty of Medicine, reveals ... that DNA methylation may play both a passive ...

(Date:6/17/2013)... to high levels of air pollution while pregnant were up ... as women who lived in areas with low pollution, according ... (HSPH). It is the first large national study to examine ... "Our findings raise concerns since, depending on the pollutant, 20% ... areas where risk of autism was elevated," said lead author ...

Breaking Biology News(10 mins):The secret of DNA methylation 2 Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2

[0] AMP joins the Federation of American Societies for Experimental Biology [0] The secret of DNA methylation [0] Exposure to high pollution levels during pregnancy may increase risk of having child with autism

... International Institute for Species Exploration at Arizona State University ... announced their picks for the top 10 new species ... Halieutichthys intermedius , a pancake batfish recently discovered by ... Natural Science, and colleagues. Halieutichthys intermedius , more ...

... is important for optimal reproductive function in both animals and ... level is important for reproductive function in various animals, but ... Hospital have shown that this relationship can also be demonstrated ... men showed a positive correlation between the percentage of motile ...

... prenatal vitamin immediately before and during the first month of ... with an autism spectrum disorder as women who did take ... times as great when combined with a high-risk genetic make-up, ... has found. "Mothers of children with autism were ...

Cached Biology News:Fish species discovered by LSU researcher makes 2011 top 10 list 2 Vitamin D increases speed of sperm cells 2 Women who start prenatal vitamins early are less likely to have children with autism 2 Women who start prenatal vitamins early are less likely to have children with autism 3 Women who start prenatal vitamins early are less likely to have children with autism 4

Fish species discovered by LSU researcher makes 2011 top 10 list Vitamin D increases speed of sperm cells Women who start prenatal vitamins early are less likely to have children with autism

Anti-Rsk2/MAPKAP Kinase 1b, #0 SK2/MAPKAP K1 beta Smartpool&t 3T3 cell lysate Non-specific Control Pool , #D 1X Universal Buffer...

TNF-R2 (L-20)...

... 500 Power Supply is designed ... offers extensive programming capabilities including ... methods for you to set ... simple intuitive PowerEase interface is ...

Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...

Biology Products:

RSK2 siRNA siAb™ Assay Kit from Upstate Goat Anti-TNF-R2 (L-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.Temperature Monitoring Probe from Invitrogen Hum Bug Noise Eliminator from AutoMate Scientific, Inc